Hancock Whitney Corp Has $1.80 Million Holdings in Akamai Technologies, Inc. (NASDAQ:AKAM)

Share on StockTwits

Hancock Whitney Corp cut its position in shares of Akamai Technologies, Inc. (NASDAQ:AKAM) by 22.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,851 shares of the technology infrastructure company’s stock after selling 6,007 shares during the quarter. Hancock Whitney Corp’s holdings in Akamai Technologies were worth $1,801,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Signaturefd LLC grew its holdings in Akamai Technologies by 11.2% in the third quarter. Signaturefd LLC now owns 1,256 shares of the technology infrastructure company’s stock worth $115,000 after purchasing an additional 126 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in Akamai Technologies by 1.2% in the third quarter. Oppenheimer Asset Management Inc. now owns 11,206 shares of the technology infrastructure company’s stock worth $1,024,000 after purchasing an additional 130 shares during the period. Parallel Advisors LLC grew its holdings in Akamai Technologies by 8.0% in the third quarter. Parallel Advisors LLC now owns 1,760 shares of the technology infrastructure company’s stock worth $161,000 after purchasing an additional 130 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Akamai Technologies by 1.3% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 10,266 shares of the technology infrastructure company’s stock worth $886,000 after purchasing an additional 130 shares during the period. Finally, LS Investment Advisors LLC grew its holdings in Akamai Technologies by 2.5% in the third quarter. LS Investment Advisors LLC now owns 6,303 shares of the technology infrastructure company’s stock worth $576,000 after purchasing an additional 151 shares during the period. Institutional investors own 89.32% of the company’s stock.

AKAM has been the subject of a number of research reports. B. Riley raised their price target on shares of Akamai Technologies from $111.00 to $120.00 and gave the stock a “buy” rating in a report on Tuesday. Zacks Investment Research upgraded shares of Akamai Technologies from a “hold” rating to a “buy” rating and set a $107.00 price target for the company in a report on Thursday. Cowen cut shares of Akamai Technologies from an “outperform” rating to a “market perform” rating in a report on Thursday, January 2nd. William Blair restated an “outperform” rating on shares of Akamai Technologies in a report on Wednesday. Finally, ValuEngine upgraded shares of Akamai Technologies from a “sell” rating to a “hold” rating in a report on Saturday. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and sixteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $100.26.

In other news, Director Bernardus Johannes M. Verwaayen sold 25,062 shares of Akamai Technologies stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $87.74, for a total transaction of $2,198,939.88. Following the completion of the transaction, the director now directly owns 25,062 shares in the company, valued at $2,198,939.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.40% of the stock is owned by company insiders.

Shares of NASDAQ AKAM opened at $99.67 on Friday. The stock has a market capitalization of $16.11 billion, a P/E ratio of 34.25, a P/E/G ratio of 2.20 and a beta of 0.53. The company has a 50-day moving average price of $93.25 and a 200-day moving average price of $89.31. Akamai Technologies, Inc. has a 1 year low of $67.28 and a 1 year high of $103.29. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.22 and a quick ratio of 3.74.

Akamai Technologies (NASDAQ:AKAM) last issued its quarterly earnings data on Tuesday, February 11th. The technology infrastructure company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.10. The firm had revenue of $772.12 million during the quarter, compared to analysts’ expectations of $749.76 million. Akamai Technologies had a net margin of 16.52% and a return on equity of 16.86%. During the same period last year, the company earned $1.07 earnings per share. As a group, equities research analysts anticipate that Akamai Technologies, Inc. will post 3.78 earnings per share for the current fiscal year.

Akamai Technologies Company Profile

Akamai Technologies, Inc provides cloud services for delivering, optimizing, and securing content and business applications over the Internet in the United States and internationally. It provides cloud security solutions, including Web Application Protector to safeguard Web assets from Web application and distributed denial of service; Kona Site Defender, a cloud security solution; Bot Manager to identify bots and categorize bots based on business or IT impact; Fast DNS, which translates human-readable domain names into numerical IP addresses; Prolexic Routed to protect Web- and IP-based applications; and Client Reputation that assigns risk scores to malicious IP address and enables customers to take action on individual clients.

Further Reading: Which market index is the best?

Want to see what other hedge funds are holding AKAM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Akamai Technologies, Inc. (NASDAQ:AKAM).

Institutional Ownership by Quarter for Akamai Technologies (NASDAQ:AKAM)

Receive News & Ratings for Akamai Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akamai Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.